News

For more than two years, the pain in Bruce Pulley’s left hip slowed him down and kept him from doing the things he loved, especially fishing. His BJC Medical Group orthopedic surgeon, Jesse Beard, DO, recommended a hip replacement as treatment to help relieve his pain, but the thought of surgery made Bruce nervous, so he put off scheduling it.

For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.

But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.